Legal & General Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-154,510
| Closed | -$6.51M | – | 3425 |
|
|
2023
Q2 | $6.51M | Sell |
154,510
-1,481
| -0.9% | -$59.9K | ﹤0.01% | 1307 |
|
|
2023
Q1 | $5.56M | Buy |
155,991
+6,363
| +4% | +$231K | ﹤0.01% | 1363 |
|
|
2022
Q4 | $5.49M | Sell |
149,628
-4,786
| -3% | -$189K | ﹤0.01% | 1357 |
|
|
2022
Q3 | $7.28M | Sell |
154,414
-1,027
| -0.7% | -$66.3K | ﹤0.01% | 1178 |
|
|
2022
Q2 | $11.1M | Sell |
155,441
-1,211
| -0.8% | -$88.5K | ﹤0.01% | 1023 |
|
|
2022
Q1 | $12.7M | Buy |
156,652
+3,759
| +2% | +$318K | ﹤0.01% | 1052 |
|
|
2021
Q4 | $15.7M | Buy |
152,893
+8,291
| +6% | +$796K | ﹤0.01% | 987 |
|
|
2021
Q3 | $12.7M | Buy |
144,602
+12,825
| +10% | +$1.16M | ﹤0.01% | 1052 |
|
|
2021
Q2 | $11.8M | Buy |
131,777
+1,678
| +1% | +$142K | ﹤0.01% | 1088 |
|
|
2021
Q1 | $9.87M | Buy |
130,099
+10,450
| +9% | +$788K | ﹤0.01% | 1206 |
|
|
2020
Q4 | $8.15M | Sell |
119,649
-7,066
| -6% | -$441K | ﹤0.01% | 1213 |
|
|
2020
Q3 | $6.74M | Buy |
126,715
+15,496
| +14% | +$923K | ﹤0.01% | 1202 |
|
|
2020
Q2 | $6.48M | Buy |
111,219
+24,016
| +28% | +$1.29M | ﹤0.01% | 1194 |
|
|
2020
Q1 | $3.44M | Buy |
87,203
+1,449
| +2% | +$84.7K | ﹤0.01% | 1339 |
|
|
2019
Q4 | $5.1M | Buy |
85,754
+5,774
| +7% | +$310K | ﹤0.01% | 1355 |
|
|
2019
Q3 | $4.25M | Buy |
79,980
+9,944
| +14% | +$510K | ﹤0.01% | 1372 |
|
|
2019
Q2 | $3.58M | Sell |
70,036
-2,604
| -4% | -$121K | ﹤0.01% | 1435 |
|
|
2019
Q1 | $3.76M | Buy |
72,640
+10,453
| +17% | +$507K | ﹤0.01% | 1366 |
|
|
2018
Q4 | $2.45M | Buy |
62,187
+1,943
| +3% | +$90.3K | ﹤0.01% | 1482 |
|
|
2018
Q3 | $3.1M | Buy |
60,244
+6,839
| +13% | +$335K | ﹤0.01% | 1485 |
|
|
2018
Q2 | $2.5M | Sell |
53,405
-1,061
| -2% | -$43.9K | ﹤0.01% | 1556 |
|
|
2018
Q1 | $1.93M | Buy |
54,466
+5,459
| +11% | +$214K | ﹤0.01% | 1632 |
|
|
2017
Q4 | $2.14M | Buy |
49,007
+1,631
| +3% | +$76.2K | ﹤0.01% | 1591 |
|
|
2017
Q3 | $2.48M | Buy |
47,376
+5,548
| +13% | +$309K | ﹤0.01% | 1462 |
|
|
2017
Q2 | $2.45M | Buy |
41,828
+26,432
| +172% | +$1.37M | ﹤0.01% | 1413 |
|
|
2017
Q1 | $703K | Sell |
15,396
-197
| -1% | -$9.8K | ﹤0.01% | 1925 |
|
|
2016
Q4 | $818K | Buy |
15,593
+5,839
| +60% | +$283K | ﹤0.01% | 1824 |
|
|
2016
Q3 | $434K | Sell |
9,754
-378
| -4% | -$16.4K | ﹤0.01% | 1764 |
|
|
2016
Q2 | $383K | Buy |
10,132
+3,836
| +61% | +$169K | ﹤0.01% | 1467 |
|
|
2016
Q1 | $260K | Buy |
6,296
+1,873
| +42% | +$77.2K | ﹤0.01% | 1639 |
|
|
2015
Q4 | $210K | Buy |
4,423
+901
| +26% | +$40.1K | ﹤0.01% | 1728 |
|
|
2015
Q3 | $142K | Buy |
3,522
+988
| +39% | +$43.2K | ﹤0.01% | 1862 |
|
|
2015
Q2 | $97K | Buy |
+2,534
| New | +$87.4K | ﹤0.01% | 2137 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Legal & General Group's SYNH Position: Q3 2023 in Review
Legal & General Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 154,510 shares — an estimated $6.51M sold.
Legal & General Group first reported a position in SYNH in Q2 2015 and held it in 33 quarters. The position peaked at $15.7M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Legal & General Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Legal & General Group sold 154,510 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $6.51M.
- Legal & General Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 33 quarters.
- Legal & General Group's Syneos Health, Inc. Class A Common Stock position peaked at $15.7M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Legal & General Group's 13F filing for Q3 2023, filed 14 Nov 2023.